|
Journal
Papers, Abstracts, and Commentaries
| |
Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative Stress
by Modulating
both Production and Scavenging of Reactive Oxygen Species.
Fujinaga H, Tsutsumi T, Yotsuyanagi H, et al
Oncology.
2011;81 Suppl 1:11-
Abstract
Survival rates of early-stage HCV-related liver cirrhosis patients without
hepatocellular carcinoma are
decreased by alcohol.
Yamada M, Shiroeda H, Hayashi
R,
et al
J Clin Biochem Nutr. 2011
Mar;48(2):167-9.
Abstract
Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma
in Patients with
Compensated Cirrhosis.
Velosa J, Serejo F,
Marinho R, Nunes J, Glória H
Dig Dis Sci. 2011 Mar 5
Abstract
High Levels of HCV core+1 Antibodies in HCV Patients with Hepatocellular
Carcinoma.
Dalagiorgou G, Vassilaki N, Foka P,
et al
J Gen Virol.
2011 Feb 9.
Abstract
Utilization of surveillance for hepatocellular carcinoma among hepatitis C
virus-infected veterans
in the United States.
Davila JA, Henderson L, Kramer JR,
et al
Ann Intern Med.
2011 Jan 18;
Abstract |
A Comparison of Prognosis between Patients with Hepatitis B and
C Virus-related Hepatocellular
Carcinoma Undergoing Resection Surgery.
Kao WY, Su CW, Chau GY, et al
World
J Surg. 2011 Jan 5.
Abstract |
Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role
in the
prevention and treatment.
Castello
G, Costantini S, Scala S.
J Transl Med. 2010 Nov 3;8(1):109
Abstract |
FULL-TEXT
ARTICLE
Insulin resistance is
associated with hepatocellular carcinoma in chronic
hepatitis C infection.
Hung CH, Wang JH, Hu TH, et al
World J Gastroenterol.
2010 May 14;16(18):2265-71.
Paper |
HCV Infection and Cryptogenic Cirrhosis are Risk Factors for Hepatocellular
Carcinoma Among Latinos in New York City.
Guerrero-Preston R, Siegel A, Renz J, et al
J Community Health. 2009
Aug 25
Abstract |
Why So High Incidence of HCC in Japan?
Mizokami M.
Gan To Kagaku Ryoho. 2009 Jul;36(7):1055-7
Abstract |
Prevention of hepatocellular carcinoma complicating
chronic hepatitis C.
Ueno Y, Sollano JD, Farrell GC.
J Gastroenterol Hepatol.
2009 Apr;24(4):531-6.
Abstract |
Development of hepatocellular carcinoma in a
patient 13 years after sustained virological
response to
interferon against chronic hepatitis C: a case report.
Mashitani T, Yoshiji H, Yamazaki M, et al
Cases J.
2009 Jan 7;2(1):18.
Abstract
|
ole of hepatitis C virus in the development of hepatocellular carcinoma:
Transgenic approach to viral hepatocarcinogenesis.
Koike K, Moriya K, Kimura S.
J Gastroenterol Hepatol 2002 Apr;17(4):394-400
Abstract
Transient biochemical response in interferon therapy decreases the
development of hepatocellular
carcinoma for five years and improves the long-term survival of chronic
hepatitis C patients.
Okanoue T, Itoh Y, Kirishima T, et al
Hepatol Res 2002 May;23(1):62-77
Abstract |
|
Conference Reports, Abstracts, and Posters
|